【摘要】 淋巴组织反应性增生与淋巴瘤在治疗和预后方面有很大的不同。临床上,尤其在病理上,明确鉴别两者有时很困难。近些年,随着分子生物学技术的发展,从免疫组织化学和遗传学等方面对两者的研究增多,为我们提供一些新的鉴别依据。更多还原

【Abstract】 Malignant lymphomas have much difference with reactive lymphoid proliferations in therapy and progn-osis.It’s difficult to distinguish them distinctly only by clinical presentation and pathologic features.In recent years,with the development of molecular biology,research in immunohistochemisty and genetics have increased,and provide us some new identification.更多还原